Maxlinear, Inc. (MXL) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Maxlinear’s revenue went from $388M in fiscal 2016 to $468M in fiscal 2025, growth of about 2.1% a year.
Net income in fiscal 2025 was -$137M, a net margin of -29.2%; the best year in this period was 2022 with $125M.
Over the twelve months to September 30, 2026, revenue was $661M and net income -$29M.
Free cash flow was $7M in fiscal 2025 and positive in 9 of the 10 years shown.
The diluted share count rose 28% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $661M | $468M | $361M | $693M | $1.1B | $892M | $479M | $317M | $385M | $420M | $388M |
| Gross profit | $383M | $266M | $195M | $386M | $650M | $496M | $213M | $168M | $209M | $208M | $230M |
| Operating income | -$6M | -$127M | -$223M | -$38M | $180M | $65M | -$101M | -$22M | -$19M | -$22M | $63M |
| Net income | -$29M | -$137M | -$245M | -$73M | $125M | $42M | -$99M | -$20M | -$26M | -$9M | $61M |
| EPS (diluted) | $-0.33 | $-1.58 | $-2.93 | $-0.91 | $1.55 | $0.53 | $-1.35 | $-0.28 | $-0.38 | $-0.14 | $0.91 |
| R&D | $222M | $209M | $225M | $270M | $296M | $278M | $180M | $98M | $120M | $112M | $98M |
| Revenue growth | — | +29.7% | −48.0% | −38.1% | +25.5% | +86.5% | +50.9% | −17.6% | −8.4% | +8.4% | +29.1% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7M | $20M | -$45M | $43M | $389M | $168M | $74M | $78M | $103M | $75M | $117M |
| Capital spending | -$13M | -$13M | -$18M | -$13M | -$41M | -$39M | -$12M | -$7M | -$8M | -$7M | -$9M |
| Free cash flow | -$21M | $7M | -$63M | $30M | $347M | $129M | $61M | $71M | $95M | $68M | $109M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | $20M | $0 | $0 | $32M | $24M | $0 | $0 | $0 | $334000 | $3000 |
| Stock-based pay | $87M | $77M | $66M | $55M | $82M | $59M | $48M | $32M | $32M | $33M | $22M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $73M | $119M | $187M | $206M | $131M | $149M | $93M | $73M | $72M | $81M |
| Debt | — | $146M | $151M | $160M | $159M | $344M | $399M | $221M | $261M | $348M | $0 |
| Equity | — | $452M | $516M | $686M | $676M | $489M | $391M | $415M | $400M | $387M | $352M |
| Total assets | — | $796M | $865M | $1.1B | $1.2B | $1.1B | $1.0B | $706M | $744M | $825M | $423M |
| Shares (diluted) | 98M | 87M | 84M | 81M | 81M | 80M | 73M | 71M | 68M | 66M | 68M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 58.0% | 56.8% | 54.0% | 55.6% | 58.0% | 55.6% | 44.5% | 52.9% | 54.2% | 49.5% | 59.3% |
| Operating margin | -0.9% | -27.1% | -62.0% | -5.5% | 16.1% | 7.3% | -21.1% | -7.0% | -5.0% | -5.2% | 16.3% |
| Net margin | -4.4% | -29.2% | -68.0% | -10.5% | 11.2% | 4.7% | -20.6% | -6.3% | -6.8% | -2.2% | 15.8% |
| FCF margin | -3.1% | 1.5% | -17.5% | 4.3% | 31.0% | 14.5% | 12.8% | 22.5% | 24.6% | 16.1% | 28.1% |
| ROIC | — | -20.6% | -26.4% | -3.6% | 15.5% | 6.9% | -11.0% | -2.1% | -2.3% | -2.3% | 17.2% |
| ROE | — | -30.2% | -47.5% | -10.7% | 18.5% | 8.6% | -25.2% | -4.8% | -6.6% | -2.4% | 17.4% |
Frequently asked questions
What is Maxlinear’s annual revenue?
$468M in fiscal 2025 and $661M over the twelve months to September 30, 2026.
How much profit does Maxlinear make?
Net income was -$137M in fiscal 2025 (net margin -29.2%).
Is Maxlinear’s revenue growing?
Yes: revenue rose 29.7% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.